Companies are supposed to design and manufacture safe products. No matter what the product is, it should be reasonably safe and, when needed, have appropriate warnings or instructions on how to use it. Unfortunately, that is not always the case. When a product is defective, it will be classified as having one of the following product defects.
In the Kansas City area and across the nation, dangerous and defective products are the cause of thousands of injuries every year. Unfortunately, many products go to market that are defective and ultimately cause serious injuries. When serious injuries are caused by supposedly safe products, what do you do?
Hundreds of adverse events associated with Bard PowerPort catheters have been reported to the FDA, and lawsuits are being filed against the manufacturers of the device over manufacturing and design problems that can cause certain parts of the catheter port and catheter tube to be susceptible to fracturing and migration.
If you have been injured after being implanted with a Bard PowerPort device, contact Nash & Franciskato at (877) 284-6600.
Since April 2021, the FDA has received more than 69,000 medical device reports (MDRs), including 168 reports of death, associated with the PE-PUR foam breakdown or suspected foam breakdown, which led to the Philips CPAP recall.
Source: FDA Safety Communication
August 11, 2022. Exactech expands hip recall, adding 40,000 more hip implants to its hip replacement recall in the U.S. The company admits to packaging problems that can cause the plastic hip liners to oxidize and wear out much sooner than expected.
June 14, 2022, a motion was filed to consolidate all Exactech joint replacement lawsuits involving recalled polyethylene inserts in hips, knees, and ankles into a federal multidistrict litigation (MDL) in the Eastern District of New York. If the motion is granted, all future Exactech recall lawsuits filed in federal court would be centralized under the MDL.
On March 10, 2022, the FDA issued a notification order to Philips Respironics requiring the company to notify patients and others of the company’s June 2021 product recall and the health risks posed by the foam used in the recalled products.
Products in this recall include:
Read the FDA Notification Order
Exactech Lawsuit: Nash & Franciskato along with co-counsel firms Cohen & Malad, LLP, and Maglio Christopher & Toale Law Firm has filed a lawsuit against Exactech, Inc., the maker of the Connexion GXL hip liner implant used in Total Hip Arthroplasty (THA) or hip replacement surgery.
Read the Press Release: Exactech Connexion GXL Hip Liner Implant Lawsuit
Nash & Franciskato has been talking with patients throughout the country who have received the Exactech Connexion GXL implants and suffered injuries associated with excessive wear to the plastic liner insert leading to early device failure.
Start Your Free Case Evaluation Now
Exactech recalled polyethylene insert due to the possibility of premature wear and degradation, expanding the initial recall of its knee and ankle replacement systems.
In August 2021, Exactech first issued a recall of its knee arthroplasty polyethylene insert packaged in non-conforming bags limiting it to only those products with a remaining shelf life of five years or greater as of August 31, 2022. However, as of February 7, 2022, that recall has been expanded to include ALL knee and ankle polyethylene inserts packaged in non-conforming bags regardless of label or shelf life.
Philips Respironics has now expanded its recall of breathing devices to include certain Trilogy Evo ventilators. In summary,
